JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB264926

Human SCYL2 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

SCYL2 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 5 bp deletion in exon 3.

View Alternative Names

AU015688, AW536445, BC030932, CVAK104, Coated vesicle-associated kinase of 104 kDa, D10Ertd802e, FLJ10074, KIAA1360, RGD1305665, SCY1 like 2 (S. cerevisiae), SCY1-like protein 2, SCYL2_HUMAN

2 Images
Sanger Sequencing - Human SCYL2 knockout HeLa cell line (AB264926)
  • Sanger seq

Unknown

Sanger Sequencing - Human SCYL2 knockout HeLa cell line (AB264926)

Allele-1 : 5 bp deletion in exon 3.

Sanger Sequencing - Human SCYL2 knockout HeLa cell line (AB264926)
  • Sanger seq

Unknown

Sanger Sequencing - Human SCYL2 knockout HeLa cell line (AB264926)

Allele-2 : 1 bp insertion in exon 3.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 5 bp deletion in exon 3

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255448). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264926-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264926 Human SCYL2 knockout HeLa cell line", "number":"AB264926-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264926-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264926 Human SCYL2 knockout HeLa cell line", "number":"AB264926-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SCYL2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SCYL2 also known by the name SCY1-like 2 is a member of the SCY1-like family of proteins. It has a mass of approximately 110 kDa. SCYL2 is an accessory protein with kinase-like activity but lacks enzymatic function. The protein localizes mainly in the trans-Golgi network and the cytoplasm. It is expressed in various tissues including brain and heart indicating its potential roles in different organs and systems within the body.
Biological function summary

The human SCYL2 protein is involved in cellular trafficking and is part of the coatomer complex which assists in vesicle formation and transport. It helps in clathrin-mediated endocytosis which is important for internalizing molecules like lipids and proteins. SCYL2 interacts with other proteins such as clathrin heavy chain and auxilin demonstrating its role in maintaining cellular homoeostasis and membrane dynamics.

Pathways

SCYL2 participates in the endocytosis and intracellular transport processes. It plays a part in the AP-2 complex pathway which is essential for the vesicle docking and cargo selection. Additionally SCYL2 associates with huntingtin an important protein involved in cellular interactions vital for neuron function and integrity connecting its role to neurological processes.

SCYL2 shows associations with neurological conditions like Huntington's disease. Disruptions in its regulatory functions can affect protein transport and neuron stability potentially leading to neurodegenerative symptoms. SCYL2 also interacts with tau proteins which are relevant in Alzheimer's disease indicating its potential influence in tauopathy-related neuronal deterioration.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com